Jochen Maas
Sanofi
Former Managing Director, Research & Development
Jochen Maas is retired as General Manager, Research & Development (R&D) at Sanofi-Aventis Deutschland GmbH, as of summer 2023. In this role, he was based in Frankfurt for more than 10 years. He was a member of the Global R&D Management Board and of the German Management Board (“Geschäftsführung”). He was appointed as head of the German Hub R&D organization in 2012 directly reporting to the global R&D president.
He has huge experience in all phases of the R&D value chain. He started his career in PK more than 20 years ago, then he expanded his responsibilities to preclinical Development, preclinical and clinical Development and Research & Development. Afterwards, he was responsible for Global Research & Development in the Diabetes Division and acted as Vice President R&D Europe at Sanofi-aventis.
Besides his activities at Sanofi and the predecessor-companies, he also holds a professorship in academia and gives lectures in pharmacokinetics and drug delivery systems at the University of Applied Sciences Gießen. He acts as vice president of the House of Pharma and Healthcare and is active member of many scientific committees and consortia.
From his background he is a biologist and veterinarian. He has a doctorate in veterinary medicine including a specification in Radiology. He studied at the Universities of Zurich, Heidelberg and Munich. He is married and has 3 sons.
He has huge experience in all phases of the R&D value chain. He started his career in PK more than 20 years ago, then he expanded his responsibilities to preclinical Development, preclinical and clinical Development and Research & Development. Afterwards, he was responsible for Global Research & Development in the Diabetes Division and acted as Vice President R&D Europe at Sanofi-aventis.
Besides his activities at Sanofi and the predecessor-companies, he also holds a professorship in academia and gives lectures in pharmacokinetics and drug delivery systems at the University of Applied Sciences Gießen. He acts as vice president of the House of Pharma and Healthcare and is active member of many scientific committees and consortia.
From his background he is a biologist and veterinarian. He has a doctorate in veterinary medicine including a specification in Radiology. He studied at the Universities of Zurich, Heidelberg and Munich. He is married and has 3 sons.